text:
http://scigraph.springernature.com/pub.10.1038/nrc3638
The ID proteins: master regulators of cancer stem cells and tumour aggressiveness View Full Text
Ontology type: schema:ScholarlyArticle
Anna Lasorella, Robert Benezra, Antonio Iavarone
Inhibitor of DNA binding (ID) proteins are transcriptional regulators that control the timing of cell fate determination and differentiation in stem and progenitor cells during normal development and adult life. ID genes are frequently deregulated in many types of human neoplasms, and they endow cancer cells with biological features that are hijacked from normal stem cells. The ability of ID proteins to function as central 'hubs' for the coordination of multiple cancer hallmarks has established these transcriptional regulators as therapeutic targets and biomarkers in specific types of human tumours. More... »
References to SciGraph publications
2012-12. The genetic landscape of mutations in Burkitt lymphoma in NATURE GENETICS
1999-10. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts in NATURE
2010-12. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells in BREAST CANCER RESEARCH AND TREATMENT
2006-02. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5 in ONCOGENE
2008-10-02. Modelling Myc inhibition as a cancer therapy in NATURE
2006-07. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth in NATURE
2013-03. Inhibition of α-helix-mediated protein–protein interactions using designed molecules in NATURE CHEMISTRY
2001-11. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth in NATURE MEDICINE
2012-12. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing in NATURE GENETICS
2001-12. The function of E- and id proteins in lymphocyte development in NATURE REVIEWS IMMUNOLOGY
2001-12. The Id proteins and angiogenesis in ONCOGENE
1999-02. Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2 in NATURE
2010-10. Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells in BRITISH JOURNAL OF CANCER
2002-07. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma in ONCOGENE
2006-07. Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases in MODERN PATHOLOGY
2009-11. KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer in NATURE CELL BIOLOGY
2005-07. Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer in ONCOGENE
2009-10. The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis in NATURE STRUCTURAL & MOLECULAR BIOLOGY
2001-02. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence in NATURE
2011-10-18. Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery in FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY
2009-02. Id-1 activates Akt-mediated Wnt signaling and p27Kip1 phosphorylation through PTEN inhibition in ONCOGENE
2003-04. Transcriptional profiling identifies Id2 function in dendritic cell development in NATURE IMMUNOLOGY
2004-03. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers in BRITISH JOURNAL OF CANCER
2012-08. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation in BREAST CANCER RESEARCH AND TREATMENT
2005-08. Id family of helix-loop-helix proteins in cancer in NATURE REVIEWS CANCER
2005-09. Migrating cancer stem cells — an integrated concept of malignant tumour progression in NATURE REVIEWS CANCER
2009-12. Identification of novel Notch target genes in T cell leukaemia in MOLECULAR CANCER
2012-08-12. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics in NATURE
2013-03. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer in ONCOGENE
2012-06. Maintaining differentiated cellular identity in NATURE REVIEWS GENETICS
2003-03. Alterations of anaphase-promoting complex genes in human colon cancer cells in ONCOGENE
2010-01. The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression in ONCOGENE
2011-12. Cyclin D1, Id1 and EMT in breast cancer in BMC CANCER
2012-05. Id proteins synchronize stemness and anchorage to the niche of neural stem cells in NATURE CELL BIOLOGY
2008-11. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-κB in MCF-7 breast cancer cells in BREAST CANCER RESEARCH AND TREATMENT
2008-01. No place like home: anatomy and function of the stem cell niche in NATURE REVIEWS MOLECULAR CELL BIOLOGY
2006-05. Ubiquitin ligases: cell-cycle control and cancer in NATURE REVIEWS CANCER
2009-04. Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation in ONCOGENE
2000-10. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins in NATURE
2010-02. Expansion and maintenance of human embryonic stem cell–derived endothelial cells by TGFβ inhibition is Id1 dependent in NATURE BIOTECHNOLOGY
2009-07. Biology of glioma cancer stem cells in MOLECULES AND CELLS
2012-09. MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma in ONCOGENE
2009-03. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? in NATURE REVIEWS CANCER
2008-12. Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver in ONCOGENE
2003-10. Identification of the haematopoietic stem cell niche and control of the niche size in NATURE
2002-11. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors in ONCOGENE
2005-03. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia in NATURE GENETICS
2005-07. Genes that mediate breast cancer metastasis to lung in NATURE
2012-08. Defining the mode of tumour growth by clonal analysis in NATURE
2009-02. TGF-β-induced epithelial to mesenchymal transition in CELL RESEARCH
2004-12. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages in NATURE
2008-12. γ-Tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways in BRITISH JOURNAL OF CANCER
2008-09. Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo in ONCOGENE
2012-02. A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20 in NATURE MEDICINE
2008-01. Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo in NATURE BIOTECHNOLOGY
Nature Reviews Cancer
FOR: Biochemistry And Cell Biology
FOR: Biological Sciences
MESH: Animals
MESH: Gene Expression Regulation, Neoplastic
MESH: Humans
MESH: Inhibitor Of Differentiation Proteins
MESH: Neoplasms
MESH: Neoplastic Stem Cells
http://dx.doi.org/10.1038/nrc3638
https://app.dimensions.ai/details/publication/pub.1010520632
Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net
"about": [
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Biochemistry and Cell Biology",
"type": "DefinedTerm"
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06",
"name": "Biological Sciences",
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"name": "Gene Expression Regulation, Neoplastic",
"name": "Humans",
"name": "Inhibitor of Differentiation Proteins",
"name": "Neoplasms",
"name": "Neoplastic Stem Cells",
"author": [
"name": [
"Institute for Cancer Genetics, Department of Pathology and Pediatrics, Columbia University Medical Center, 1130 St. Nicholas Avenue, New York, 10032 New York, USA."
"familyName": "Lasorella",
"givenName": "Anna",
"alternateName": "Memorial Sloan Kettering Cancer Center",
"id": "https://www.grid.ac/institutes/grid.51462.34",
"Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 241, New York, 10065 New York, USA."
"familyName": "Benezra",
"givenName": "Robert",
"id": "sg:person.0674175575.90",
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674175575.90"
"Institute for Cancer Genetics, Department of Pathology and Neurology, Columbia University Medical Center, 1130 St. Nicholas Avenue, New York, 10032 New York, USA."
"familyName": "Iavarone",
"givenName": "Antonio",
"citation": [
"id": "https://doi.org/10.1016/j.ccr.2011.11.025",
"https://app.dimensions.ai/details/publication/pub.1000030038"
"type": "CreativeWork"
"id": "https://doi.org/10.1158/1078-0432.ccr-10-3381",
"id": "sg:pub.10.1038/44334",
"https://app.dimensions.ai/details/publication/pub.1001061614",
"https://doi.org/10.1038/44334"
"id": "https://doi.org/10.1128/mcb.21.21.7416-7428.2001",
"id": "sg:pub.10.1038/onc.2009.325",
"https://doi.org/10.1038/onc.2009.325"
"id": "https://doi.org/10.1242/jcs.01145",
"id": "https://doi.org/10.1016/j.ejca.2010.11.009",
"id": "sg:pub.10.1038/35036504",
"https://doi.org/10.1038/35036504"
"id": "https://doi.org/10.1002/cam4.19",
"id": "https://doi.org/10.1016/j.ydbio.2005.02.001",
"id": "sg:pub.10.1038/onc.2009.56",
"https://doi.org/10.1038/onc.2009.56"
"id": "https://doi.org/10.1158/0008-5472.can-09-3186",
"id": "https://doi.org/10.1016/j.cell.2006.06.044",
"id": "https://doi.org/10.1097/jto.0b013e31824fe976",
"id": "sg:pub.10.1038/nature07260",
"https://doi.org/10.1038/nature07260"
"id": "sg:pub.10.1038/nbt1366",
"https://doi.org/10.1038/nbt1366"
"id": "https://doi.org/10.1016/s0065-230x(04)92004-0",
"id": "sg:pub.10.1038/cr.2009.5",
"https://doi.org/10.1038/cr.2009.5"
"id": "https://doi.org/10.1002/ijc.20875",
"id": "https://doi.org/10.1126/science.1171643",
"id": "https://doi.org/10.1128/mcb.24.7.2662-2672.2004",
"id": "https://doi.org/10.1016/j.bbamcr.2004.10.003",
"id": "sg:pub.10.1038/ni903",
"https://doi.org/10.1038/ni903"
"id": "sg:pub.10.1038/nrc1673",
"https://doi.org/10.1038/nrc1673"
"id": "https://doi.org/10.1073/pnas.98.1.130",
"id": "https://doi.org/10.1242/dev.083139",
"id": "https://doi.org/10.1016/j.ceb.2009.06.004",
"id": "https://doi.org/10.1073/pnas.88.5.1815",
"id": "https://doi.org/10.1073/pnas.2031337100",
"id": "https://doi.org/10.1128/mcb.16.6.2570",
"id": "https://doi.org/10.1016/j.jss.2009.08.006",
"id": "https://doi.org/10.1016/s1097-2765(03)00109-6",
"id": "https://doi.org/10.1016/j.tem.2012.04.002",
"id": "sg:pub.10.1038/nbt.1605",
"https://doi.org/10.1038/nbt.1605"
"id": "https://doi.org/10.1002/cncr.21259",
"id": "sg:pub.10.1038/ncb1974",
"https://doi.org/10.1038/ncb1974"
"id": "sg:pub.10.1007/s10549-010-0810-6",
"https://doi.org/10.1007/s10549-010-0810-6"
"id": "sg:pub.10.1038/nchem.1568",
"https://doi.org/10.1038/nchem.1568"
"id": "https://doi.org/10.1002/psc.1216",
"id": "https://doi.org/10.1016/j.conb.2010.10.002",
"id": "https://doi.org/10.1371/journal.pone.0001338",
"id": "sg:pub.10.1186/1476-4598-8-35",
"https://doi.org/10.1186/1476-4598-8-35"
"id": "https://doi.org/10.1016/j.athoracsur.2012.01.102",
"id": "https://doi.org/10.1073/pnas.162373999",
"id": "https://doi.org/10.1016/j.stem.2010.02.018",
"id": "https://doi.org/10.1182/blood-2007-01-069914",
"id": "https://doi.org/10.5625/lar.2011.27.4.333",
"id": "https://doi.org/10.1016/j.bcp.2011.05.020",
"id": "https://doi.org/10.1128/mcb.01311-10",
"id": "https://doi.org/10.1016/j.leukres.2009.09.031",
"id": "https://doi.org/10.1128/mcb.17.12.7317",
"id": "https://doi.org/10.1002/stem.660",
"id": "https://doi.org/10.1016/b978-0-12-385940-2.00005-x",
"id": "https://doi.org/10.1126/scitranslmed.3003778",
"id": "https://doi.org/10.1146/annurev-cellbio-101512-122319",
"id": "https://doi.org/10.1242/jcs.088773",
"id": "https://doi.org/10.1128/mcb.21.2.524-533.2001",
"id": "https://doi.org/10.1084/jem.20030802",
"id": "sg:pub.10.1038/ng.2468",
"https://doi.org/10.1038/ng.2468"
"id": "https://doi.org/10.1074/jbc.m606669200",
"id": "https://doi.org/10.1042/bst0380065",
"id": "https://doi.org/10.1016/j.neuron.2011.05.004",
"id": "https://doi.org/10.1093/carcin/bgs027",
"id": "sg:pub.10.1038/modpathol.3800602",
"https://doi.org/10.1038/modpathol.3800602"
"id": "sg:pub.10.1007/128_2011_265",
"https://doi.org/10.1007/128_2011_265"
"id": "sg:pub.10.1038/sj.onc.1209110",
"https://doi.org/10.1038/sj.onc.1209110"
"id": "https://doi.org/10.1101/gad.1668708",
"id": "sg:pub.10.1038/sj.bjc.6604763",
"https://doi.org/10.1038/sj.bjc.6604763"
"id": "https://doi.org/10.1242/dev.01430",
"id": "https://doi.org/10.1016/s1535-6108(03)00240-x",
"id": "https://doi.org/10.1101/gad.8.11.1270",
"id": "https://doi.org/10.1038/emboj.2011.486",
"id": "https://doi.org/10.1016/j.yexcr.2007.04.001",
"id": "https://doi.org/10.1083/jcb.201109045",
"id": "https://doi.org/10.1111/j.1365-2559.2007.02637.x",
"id": "sg:pub.10.1038/nrg3209",
"https://doi.org/10.1038/nrg3209"
"id": "https://doi.org/10.1016/j.devcel.2007.05.014",
"id": "https://doi.org/10.1046/j.1432-0436.2002.690413.x",
"id": "https://doi.org/10.1093/carcin/bgi217",
"id": "https://doi.org/10.1016/j.celrep.2013.11.014",
"id": "https://doi.org/10.1172/jci66027",
"id": "https://doi.org/10.1093/nar/22.5.749",
"id": "sg:pub.10.1038/ng1521",
"https://doi.org/10.1038/ng1521"
"id": "sg:pub.10.1038/nm.2596",
"https://doi.org/10.1038/nm.2596"
"id": "https://doi.org/10.1016/0092-8674(90)90696-c",
"id": "https://doi.org/10.1093/emboj/19.21.5772",
"id": "sg:pub.10.1038/nsmb.1669",
"https://doi.org/10.1038/nsmb.1669"
"id": "https://doi.org/10.1002/jcb.22911",
"id": "sg:pub.10.1186/1471-2407-11-417",
"https://doi.org/10.1186/1471-2407-11-417"
"id": "https://doi.org/10.1369/jhc.2009.953182",
"id": "https://doi.org/10.1093/emboj/18.4.968",
"id": "https://doi.org/10.1146/annurev.immunol.20.092501.162048",
"id": "https://doi.org/10.1038/sj.emboj.7600017",
"id": "https://doi.org/10.1158/1541-7786.mcr-10-0535",
"id": "https://doi.org/10.1016/0092-8674(90)90214-y",
"id": "https://doi.org/10.1016/j.semcancer.2012.04.001",
"id": "https://doi.org/10.2353/ajpath.2006.060020",
"id": "sg:pub.10.1038/nm1101-1194",
"https://doi.org/10.1038/nm1101-1194"
"id": "sg:pub.10.1038/nrm2319",
"https://doi.org/10.1038/nrm2319"
"id": "https://doi.org/10.1593/neo.121044",
"id": "https://doi.org/10.1016/0092-8674(90)90212-w",
"id": "https://doi.org/10.1016/0092-8674(90)90213-x",
"id": "https://doi.org/10.1089/scd.2011.0428",
"id": "https://doi.org/10.1126/scisignal.2003002",
"id": "https://doi.org/10.1210/en.2008-1797",
"id": "https://doi.org/10.3892/ijo.28.4.847",
"id": "https://doi.org/10.4161/cbt.10.3.12454",
"id": "https://doi.org/10.4161/cbt.5.5.2597",
"id": "https://doi.org/10.7150/jca.1.1",
"id": "https://doi.org/10.1096/fasebj.13.15.2257",
"id": "https://app.dimensions.ai/details/publication/pub.1074608453",
"id": "https://doi.org/10.14670/hh-21.995",
"datePublished": "2014-02",
"datePublishedReg": "2014-02-01",
"description": "Inhibitor of DNA binding (ID) proteins are transcriptional regulators that control the timing of cell fate determination and differentiation in stem and progenitor cells during normal development and adult life. ID genes are frequently deregulated in many types of human neoplasms, and they endow cancer cells with biological features that are hijacked from normal stem cells. The ability of ID proteins to function as central 'hubs' for the coordination of multiple cancer hallmarks has established these transcriptional regulators as therapeutic targets and biomarkers in specific types of human tumours. ",
"genre": "research_article",
"inLanguage": [
"en"
"isAccessibleForFree": false,
"isPartOf": [
"id": "sg:journal.1029716",
"issn": [
"1474-175X",
"1474-1768"
"name": "Nature Reviews Cancer",
"type": "Periodical"
"issueNumber": "2",
"type": "PublicationIssue"
"type": "PublicationVolume",
"volumeNumber": "14"
"name": "The ID proteins: master regulators of cancer stem cells and tumour aggressiveness",
"pagination": "77-91",
"productId": [
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"321eefd150caab170505e455627bd93b22b4bb02dd02b7a52042e96a0a411c5c"
"name": "pubmed_id",
"24442143"
"name": "nlm_unique_id",
"101124168"
"name": "doi",
"10.1038/nrc3638"
"name": "dimensions_id",
"pub.1010520632"
"https://doi.org/10.1038/nrc3638",
"sdDataset": "articles",
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000422.jsonl",
"type": "ScholarlyArticle",
"url": "http://www.nature.com/articles/nrc3638"
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nrc3638'
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nrc3638'
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nrc3638'
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nrc3638'
863 TRIPLES 21 PREDICATES 269 URIs 27 LITERALS 15 BLANK NODES
1 sg:pub.10.1038/nrc3638 schema:about N3a4f6100f6ec46488e599573d4380080
2 ″ ″ N6485cbcaa76a4053be5f8d87db81c3e4
3 ″ ″ N71de6485e0124696be2dff6ad14ceca3
4 ″ ″ Nccc0b79d4300446aa74dce6eb11d910b
5 ″ ″ Nd3f1766d64bf42999f5abb9d8004578e
6 ″ ″ Nf64339b154cb43aeaaba7bc1fd3d7c6f
7 ″ ″ anzsrc-for:06
8 ″ ″ anzsrc-for:0601
9 ″ schema:author N5882a4a65e8144999c2ead452150fede
10 ″ schema:citation sg:pub.10.1007/128_2011_265
11 ″ ″ sg:pub.10.1007/s10059-009-0111-2
15 ″ ″ sg:pub.10.1038/17812
16 ″ ″ sg:pub.10.1038/35036504
20 ″ ″ sg:pub.10.1038/cr.2009.5
21 ″ ″ sg:pub.10.1038/modpathol.3800602
22 ″ ″ sg:pub.10.1038/nature02041
29 ″ ″ sg:pub.10.1038/nbt.1605
30 ″ ″ sg:pub.10.1038/nbt1366
31 ″ ″ sg:pub.10.1038/ncb1974
33 ″ ″ sg:pub.10.1038/nchem.1568
34 ″ ″ sg:pub.10.1038/ng.2468
36 ″ ″ sg:pub.10.1038/ng1521
37 ″ ″ sg:pub.10.1038/ni903
38 ″ ″ sg:pub.10.1038/nm.2596
39 ″ ″ sg:pub.10.1038/nm1101-1194
40 ″ ″ sg:pub.10.1038/nrc1673
44 ″ ″ sg:pub.10.1038/nrg3209
45 ″ ″ sg:pub.10.1038/nrm2319
46 ″ ″ sg:pub.10.1038/nsmb.1669
47 ″ ″ sg:pub.10.1038/onc.2008.175
51 ″ ″ sg:pub.10.1038/onc.2009.56
54 ″ ″ sg:pub.10.1038/sj.bjc.6601684
57 ″ ″ sg:pub.10.1038/sj.onc.1205160
63 ″ ″ sg:pub.10.1186/1471-2407-11-417
64 ″ ″ sg:pub.10.1186/1476-4598-8-35
65 ″ ″ https://app.dimensions.ai/details/publication/pub.1074608453
70 ″ ″ https://doi.org/10.1002/cam4.19
71 ″ ″ https://doi.org/10.1002/cncr.21259
72 ″ ″ https://doi.org/10.1002/ijc.20875
77 ″ ″ https://doi.org/10.1002/jcb.22911
78 ″ ″ https://doi.org/10.1002/psc.1216
79 ″ ″ https://doi.org/10.1002/stem.660
80 ″ ″ https://doi.org/10.1016/0092-8674(90)90212-w
81 ″ ″ https://doi.org/10.1016/0092-8674(90)90213-x
82 ″ ″ https://doi.org/10.1016/0092-8674(90)90214-y
83 ″ ″ https://doi.org/10.1016/0092-8674(90)90696-c
84 ″ ″ https://doi.org/10.1016/b978-0-12-385940-2.00005-x
85 ″ ″ https://doi.org/10.1016/j.athoracsur.2012.01.102
86 ″ ″ https://doi.org/10.1016/j.bbamcr.2004.10.003
87 ″ ″ https://doi.org/10.1016/j.bcp.2011.05.020
88 ″ ″ https://doi.org/10.1016/j.ccr.2006.11.020
94 ″ ″ https://doi.org/10.1016/j.ceb.2009.06.004
95 ″ ″ https://doi.org/10.1016/j.cell.2004.07.004
100 ″ ″ https://doi.org/10.1016/j.cell.2010.11.049
104 ″ ″ https://doi.org/10.1016/j.celrep.2013.11.014
105 ″ ″ https://doi.org/10.1016/j.conb.2010.10.002
106 ″ ″ https://doi.org/10.1016/j.devcel.2007.05.014
107 ″ ″ https://doi.org/10.1016/j.ejca.2010.11.009
108 ″ ″ https://doi.org/10.1016/j.jss.2009.08.006
109 ″ ″ https://doi.org/10.1016/j.leukres.2009.09.031
110 ″ ″ https://doi.org/10.1016/j.neuron.2011.05.004
111 ″ ″ https://doi.org/10.1016/j.semcancer.2012.04.001
112 ″ ″ https://doi.org/10.1016/j.stem.2009.06.016
117 ″ ″ https://doi.org/10.1016/j.tem.2012.04.002
118 ″ ″ https://doi.org/10.1016/j.ydbio.2005.02.001
119 ″ ″ https://doi.org/10.1016/j.yexcr.2007.04.001
121 ″ ″ https://doi.org/10.1016/s0002-9440(10)65180-2
122 ″ ″ https://doi.org/10.1016/s0065-230x(04)92004-0
124 ″ ″ https://doi.org/10.1016/s0092-8674(03)00847-x
133 ″ ″ https://doi.org/10.1038/emboj.2011.486
134 ″ ″ https://doi.org/10.1038/sj.emboj.7600017
135 ″ ″ https://doi.org/10.1042/bst0380065
136 ″ ″ https://doi.org/10.1046/j.1432-0436.2002.690413.x
137 ″ ″ https://doi.org/10.1073/pnas.0607894104
138 ″ ″ https://doi.org/10.1073/pnas.062181799
148 ″ ″ https://doi.org/10.1073/pnas.88.5.1815
150 ″ ″ https://doi.org/10.1073/pnas.98.1.130
151 ″ ″ https://doi.org/10.1074/jbc.m211991200
156 ″ ″ https://doi.org/10.1083/jcb.201109045
157 ″ ″ https://doi.org/10.1084/jem.20030802
158 ″ ″ https://doi.org/10.1089/scd.2011.0428
160 ″ ″ https://doi.org/10.1093/carcin/bgi217
161 ″ ″ https://doi.org/10.1093/carcin/bgs027
162 ″ ″ https://doi.org/10.1093/emboj/18.4.968
163 ″ ″ https://doi.org/10.1093/emboj/19.21.5772
164 ″ ″ https://doi.org/10.1093/nar/22.5.749
165 ″ ″ https://doi.org/10.1096/fasebj.13.15.2257
166 ″ ″ https://doi.org/10.1097/jto.0b013e31824fe976
167 ″ ″ https://doi.org/10.1101/gad.1668708
168 ″ ″ https://doi.org/10.1101/gad.8.11.1270
169 ″ ″ https://doi.org/10.1111/j.1365-2559.2007.02637.x
171 ″ ″ https://doi.org/10.1126/science.1102612
177 ″ ″ https://doi.org/10.1126/scisignal.2003002
178 ″ ″ https://doi.org/10.1126/scitranslmed.3003778
179 ″ ″ https://doi.org/10.1128/mcb.00434-13
182 ″ ″ https://doi.org/10.1128/mcb.11.11.5603
183 ″ ″ https://doi.org/10.1128/mcb.16.5.2418
190 ″ ″ https://doi.org/10.1128/mcb.20.2.429-440.2000
192 ″ ″ https://doi.org/10.1128/mcb.21.21.7416-7428.2001
194 ″ ″ https://doi.org/10.1128/mcb.24.7.2662-2672.2004
196 ″ ″ https://doi.org/10.1146/annurev-cellbio-101512-122319
197 ″ ″ https://doi.org/10.1146/annurev.immunol.20.092501.162048
198 ″ ″ https://doi.org/10.1158/0008-5472.can-04-2095
208 ″ ″ https://doi.org/10.1158/1078-0432.ccr-03-0933
212 ″ ″ https://doi.org/10.1158/1541-7786.mcr-10-0535
213 ″ ″ https://doi.org/10.1172/jci63811
215 ″ ″ https://doi.org/10.1182/blood-2007-01-069914
221 ″ ″ https://doi.org/10.1210/en.2008-1797
222 ″ ″ https://doi.org/10.1242/dev.01430
223 ″ ″ https://doi.org/10.1242/dev.024398
226 ″ ″ https://doi.org/10.1242/jcs.00224
228 ″ ″ https://doi.org/10.1242/jcs.088773
230 ″ ″ https://doi.org/10.1369/jhc.2009.953182
231 ″ ″ https://doi.org/10.1371/journal.pone.0001338
236 ″ ″ https://doi.org/10.14670/hh-21.995
237 ″ ″ https://doi.org/10.1593/neo.121044
238 ″ ″ https://doi.org/10.2353/ajpath.2006.060020
239 ″ ″ https://doi.org/10.3892/ijo.28.4.847
240 ″ ″ https://doi.org/10.4161/cbt.10.3.12454
241 ″ ″ https://doi.org/10.4161/cbt.5.5.2597
242 ″ ″ https://doi.org/10.5625/lar.2011.27.4.333
243 ″ ″ https://doi.org/10.7150/jca.1.1
244 ″ schema:datePublished 2014-02
245 ″ schema:datePublishedReg 2014-02-01
246 ″ schema:description Inhibitor of DNA binding (ID) proteins are transcriptional regulators that control the timing of cell fate determination and differentiation in stem and progenitor cells during normal development and adult life. ID genes are frequently deregulated in many types of human neoplasms, and they endow cancer cells with biological features that are hijacked from normal stem cells. The ability of ID proteins to function as central 'hubs' for the coordination of multiple cancer hallmarks has established these transcriptional regulators as therapeutic targets and biomarkers in specific types of human tumours.
247 ″ schema:genre research_article
248 ″ schema:inLanguage en
249 ″ schema:isAccessibleForFree false
250 ″ schema:isPartOf Nbcb48dbc575041c38b7d07fa5181f59d
251 ″ ″ Ncb655fa9e2bf45d19fb44a60128542af
252 ″ ″ sg:journal.1029716
253 ″ schema:name The ID proteins: master regulators of cancer stem cells and tumour aggressiveness
254 ″ schema:pagination 77-91
255 ″ schema:productId N29e12cb07ab84f25832c460989e737f9
256 ″ ″ N81e35e165924453888fa5d1d1e160769
257 ″ ″ Na8420baed6054c51951a7c3f8a6d1986
258 ″ ″ Nd2c1edec0d29458b972a417b2d3b20ae
259 ″ ″ Nf9e3f89acbd147bab781148e50388727
260 ″ schema:sameAs https://app.dimensions.ai/details/publication/pub.1010520632
261 ″ ″ https://doi.org/10.1038/nrc3638
262 ″ schema:sdDatePublished 2019-04-10T14:47
263 ″ schema:sdLicense https://scigraph.springernature.com/explorer/license/
264 ″ schema:sdPublisher Ne82678b346b64230b38cd8f06409d582
265 ″ schema:url http://www.nature.com/articles/nrc3638
266 ″ sgo:license sg:explorer/license/
267 ″ sgo:sdDataset articles
268 ″ rdf:type schema:ScholarlyArticle
269 N007e290f0f2541a6a9b02195ccd48356 schema:name Institute for Cancer Genetics, Department of Pathology and Neurology, Columbia University Medical Center, 1130 St. Nicholas Avenue, New York, 10032 New York, USA.
270 ″ rdf:type schema:Organization
271 N0fad1e7e4b074bbcb22b4e7c4663ad90 rdf:first sg:person.0743765737.26
272 ″ rdf:rest rdf:nil
273 N29e12cb07ab84f25832c460989e737f9 schema:name doi
274 ″ schema:value 10.1038/nrc3638
275 ″ rdf:type schema:PropertyValue
276 N372b9d169dfe4fad874f0d8ec55770bd schema:name Institute for Cancer Genetics, Department of Pathology and Pediatrics, Columbia University Medical Center, 1130 St. Nicholas Avenue, New York, 10032 New York, USA.
278 N3a4f6100f6ec46488e599573d4380080 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
279 ″ schema:name Neoplastic Stem Cells
280 ″ rdf:type schema:DefinedTerm
281 N5882a4a65e8144999c2ead452150fede rdf:first sg:person.01104624007.32
282 ″ rdf:rest Nc691d60163364db78fa65d85cb4e3c93
283 N6485cbcaa76a4053be5f8d87db81c3e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
284 ″ schema:name Humans
286 N71de6485e0124696be2dff6ad14ceca3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
287 ″ schema:name Gene Expression Regulation, Neoplastic
289 N81e35e165924453888fa5d1d1e160769 schema:name readcube_id
290 ″ schema:value 321eefd150caab170505e455627bd93b22b4bb02dd02b7a52042e96a0a411c5c
292 Na8420baed6054c51951a7c3f8a6d1986 schema:name nlm_unique_id
293 ″ schema:value 101124168
295 Nbcb48dbc575041c38b7d07fa5181f59d schema:volumeNumber 14
296 ″ rdf:type schema:PublicationVolume
297 Nc691d60163364db78fa65d85cb4e3c93 rdf:first sg:person.0674175575.90
298 ″ rdf:rest N0fad1e7e4b074bbcb22b4e7c4663ad90
299 Ncb655fa9e2bf45d19fb44a60128542af schema:issueNumber 2
300 ″ rdf:type schema:PublicationIssue
301 Nccc0b79d4300446aa74dce6eb11d910b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
302 ″ schema:name Inhibitor of Differentiation Proteins
304 Nd2c1edec0d29458b972a417b2d3b20ae schema:name pubmed_id
305 ″ schema:value 24442143
307 Nd3f1766d64bf42999f5abb9d8004578e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
308 ″ schema:name Animals
310 Ne82678b346b64230b38cd8f06409d582 schema:name Springer Nature - SN SciGraph project
312 Nf64339b154cb43aeaaba7bc1fd3d7c6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
313 ″ schema:name Neoplasms
315 Nf9e3f89acbd147bab781148e50388727 schema:name dimensions_id
316 ″ schema:value pub.1010520632
318 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
319 ″ schema:name Biological Sciences
321 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
322 ″ schema:name Biochemistry and Cell Biology
324 sg:journal.1029716 schema:issn 1474-175X
325 ″ ″ 1474-1768
326 ″ schema:name Nature Reviews Cancer
327 ″ rdf:type schema:Periodical
328 sg:person.01104624007.32 schema:affiliation N372b9d169dfe4fad874f0d8ec55770bd
329 ″ schema:familyName Lasorella
330 ″ schema:givenName Anna
331 ″ schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104624007.32
332 ″ rdf:type schema:Person
333 sg:person.0674175575.90 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
334 ″ schema:familyName Benezra
335 ″ schema:givenName Robert
336 ″ schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674175575.90
338 sg:person.0743765737.26 schema:affiliation N007e290f0f2541a6a9b02195ccd48356
339 ″ schema:familyName Iavarone
340 ″ schema:givenName Antonio
343 sg:pub.10.1007/128_2011_265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024249407
344 ″ ″ https://doi.org/10.1007/128_2011_265
345 ″ rdf:type schema:CreativeWork
346 sg:pub.10.1007/s10059-009-0111-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036609384
347 ″ ″ https://doi.org/10.1007/s10059-009-0111-2
358 sg:pub.10.1038/17812 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045754219
359 ″ ″ https://doi.org/10.1038/17812
361 sg:pub.10.1038/35036504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002136412
362 ″ ″ https://doi.org/10.1038/35036504
373 sg:pub.10.1038/cr.2009.5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004224732
374 ″ ″ https://doi.org/10.1038/cr.2009.5
376 sg:pub.10.1038/modpathol.3800602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023558299
377 ″ ″ https://doi.org/10.1038/modpathol.3800602
379 sg:pub.10.1038/nature02041 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033616640
380 ″ ″ https://doi.org/10.1038/nature02041
400 sg:pub.10.1038/nbt.1605 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010183443
401 ″ ″ https://doi.org/10.1038/nbt.1605
403 sg:pub.10.1038/nbt1366 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003426939
404 ″ ″ https://doi.org/10.1038/nbt1366
406 sg:pub.10.1038/ncb1974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011609648
407 ″ ″ https://doi.org/10.1038/ncb1974
412 sg:pub.10.1038/nchem.1568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013054512
413 ″ ″ https://doi.org/10.1038/nchem.1568
415 sg:pub.10.1038/ng.2468 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020681837
416 ″ ″ https://doi.org/10.1038/ng.2468
421 sg:pub.10.1038/ng1521 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040006580
422 ″ ″ https://doi.org/10.1038/ng1521
424 sg:pub.10.1038/ni903 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005801952
425 ″ ″ https://doi.org/10.1038/ni903
427 sg:pub.10.1038/nm.2596 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040241596
428 ″ ″ https://doi.org/10.1038/nm.2596
430 sg:pub.10.1038/nm1101-1194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050308225
431 ″ ″ https://doi.org/10.1038/nm1101-1194
433 sg:pub.10.1038/nrc1673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006049482
445 sg:pub.10.1038/nrg3209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031496732
446 ″ ″ https://doi.org/10.1038/nrg3209
448 sg:pub.10.1038/nrm2319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052316353
449 ″ ″ https://doi.org/10.1038/nrm2319
451 sg:pub.10.1038/nsmb.1669 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042783117
452 ″ ″ https://doi.org/10.1038/nsmb.1669
454 sg:pub.10.1038/onc.2008.175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016413703
455 ″ ″ https://doi.org/10.1038/onc.2008.175
466 sg:pub.10.1038/onc.2009.56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002193814
467 ″ ″ https://doi.org/10.1038/onc.2009.56
475 sg:pub.10.1038/sj.bjc.6601684 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034127048
476 ″ ″ https://doi.org/10.1038/sj.bjc.6601684
484 sg:pub.10.1038/sj.onc.1205160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031715623
485 ″ ″ https://doi.org/10.1038/sj.onc.1205160
502 sg:pub.10.1186/1471-2407-11-417 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043839283
503 ″ ″ https://doi.org/10.1186/1471-2407-11-417
505 sg:pub.10.1186/1476-4598-8-35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014703898
506 ″ ″ https://doi.org/10.1186/1476-4598-8-35
508 https://app.dimensions.ai/details/publication/pub.1074608453 ″ schema:CreativeWork
513 https://doi.org/10.1002/cam4.19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002137136
515 https://doi.org/10.1002/cncr.21259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010975812
517 https://doi.org/10.1002/ijc.20875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004336483
527 https://doi.org/10.1002/jcb.22911 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043529588
529 https://doi.org/10.1002/psc.1216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013121852
531 https://doi.org/10.1002/stem.660 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017836399
533 https://doi.org/10.1016/0092-8674(90)90212-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1053225968
535 https://doi.org/10.1016/0092-8674(90)90213-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053521727
537 https://doi.org/10.1016/0092-8674(90)90214-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046578655
539 https://doi.org/10.1016/0092-8674(90)90696-c schema:sameAs https://app.dimensions.ai/details/publication/pub.1041327415
541 https://doi.org/10.1016/b978-0-12-385940-2.00005-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018033608
543 https://doi.org/10.1016/j.athoracsur.2012.01.102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014782252
545 https://doi.org/10.1016/j.bbamcr.2004.10.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005619842
547 https://doi.org/10.1016/j.bcp.2011.05.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016847653
549 https://doi.org/10.1016/j.ccr.2006.11.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007921851
561 https://doi.org/10.1016/j.ceb.2009.06.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008302567
563 https://doi.org/10.1016/j.cell.2004.07.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033486035
581 https://doi.org/10.1016/j.celrep.2013.11.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037595302
583 https://doi.org/10.1016/j.conb.2010.10.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013262287
585 https://doi.org/10.1016/j.devcel.2007.05.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032617059
587 https://doi.org/10.1016/j.ejca.2010.11.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001929200
589 https://doi.org/10.1016/j.jss.2009.08.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009322656
591 https://doi.org/10.1016/j.leukres.2009.09.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017125422
593 https://doi.org/10.1016/j.neuron.2011.05.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022505652
595 https://doi.org/10.1016/j.semcancer.2012.04.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046676156
597 https://doi.org/10.1016/j.stem.2009.06.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042035236
607 https://doi.org/10.1016/j.tem.2012.04.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010170622
609 https://doi.org/10.1016/j.ydbio.2005.02.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002171504
611 https://doi.org/10.1016/j.yexcr.2007.04.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030235045
615 https://doi.org/10.1016/s0002-9440(10)65180-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014404202
617 https://doi.org/10.1016/s0065-230x(04)92004-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003451493
621 https://doi.org/10.1016/s0092-8674(03)00847-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031003004
639 https://doi.org/10.1038/emboj.2011.486 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029409822
641 https://doi.org/10.1038/sj.emboj.7600017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044803804
643 https://doi.org/10.1042/bst0380065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021803036
645 https://doi.org/10.1046/j.1432-0436.2002.690413.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034362910
647 https://doi.org/10.1073/pnas.0607894104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035940367
649 https://doi.org/10.1073/pnas.062181799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040796417
669 https://doi.org/10.1073/pnas.88.5.1815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008953179
673 https://doi.org/10.1073/pnas.98.1.130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007293453
675 https://doi.org/10.1074/jbc.m211991200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048849236
685 https://doi.org/10.1083/jcb.201109045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030261578
687 https://doi.org/10.1084/jem.20030802 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019658367
689 https://doi.org/10.1089/scd.2011.0428 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059310446
693 https://doi.org/10.1093/carcin/bgi217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035482198
695 https://doi.org/10.1093/carcin/bgs027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023516462
697 https://doi.org/10.1093/emboj/18.4.968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044072244
699 https://doi.org/10.1093/emboj/19.21.5772 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042740538
701 https://doi.org/10.1093/nar/22.5.749 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039282363
703 https://doi.org/10.1096/fasebj.13.15.2257 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074561299
705 https://doi.org/10.1097/jto.0b013e31824fe976 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002889335
707 https://doi.org/10.1101/gad.1668708 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025933844
709 https://doi.org/10.1101/gad.8.11.1270 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029225233
711 https://doi.org/10.1111/j.1365-2559.2007.02637.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030697909
715 https://doi.org/10.1126/science.1102612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062450991
727 https://doi.org/10.1126/scisignal.2003002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062682580
729 https://doi.org/10.1126/scitranslmed.3003778 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018191440
731 https://doi.org/10.1128/mcb.00434-13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034844125
737 https://doi.org/10.1128/mcb.11.11.5603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027971423
739 https://doi.org/10.1128/mcb.16.5.2418 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035896446
753 https://doi.org/10.1128/mcb.20.2.429-440.2000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034858817
757 https://doi.org/10.1128/mcb.21.21.7416-7428.2001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001570792
761 https://doi.org/10.1128/mcb.24.7.2662-2672.2004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005080826
765 https://doi.org/10.1146/annurev-cellbio-101512-122319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018463203
767 https://doi.org/10.1146/annurev.immunol.20.092501.162048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044509069
769 https://doi.org/10.1158/0008-5472.can-04-2095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017184639
789 https://doi.org/10.1158/1078-0432.ccr-03-0933 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002860674
797 https://doi.org/10.1158/1541-7786.mcr-10-0535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045412121
799 https://doi.org/10.1172/jci63811 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039223548
803 https://doi.org/10.1182/blood-2007-01-069914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016656795
815 https://doi.org/10.1210/en.2008-1797 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064249886
817 https://doi.org/10.1242/dev.01430 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027781724
819 https://doi.org/10.1242/dev.024398 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047459818
825 https://doi.org/10.1242/jcs.00224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047245619
829 https://doi.org/10.1242/jcs.088773 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019290550
833 https://doi.org/10.1369/jhc.2009.953182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043913288
835 https://doi.org/10.1371/journal.pone.0001338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014520697
845 https://doi.org/10.14670/hh-21.995 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077253216
847 https://doi.org/10.1593/neo.121044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053052575
849 https://doi.org/10.2353/ajpath.2006.060020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048961082
851 https://doi.org/10.3892/ijo.28.4.847 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071515983
853 https://doi.org/10.4161/cbt.10.3.12454 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072292258
855 https://doi.org/10.4161/cbt.5.5.2597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072294111
857 https://doi.org/10.5625/lar.2011.27.4.333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016695856
859 https://doi.org/10.7150/jca.1.1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073619542
861 https://www.grid.ac/institutes/grid.51462.34 schema:alternateName Memorial Sloan Kettering Cancer Center
862 ″ schema:name Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 241, New York, 10065 New York, USA.


"Doing innovative business with MAIN"
MAINnovations are future-oriented innovative products AND services, developed by MAIN that will help you in doing future business! Our MAINnovations enable you to have an easy and transparent insight into your energy consumption. You have real-time data available to monitor your consumption and to stop unnecessary consumption. This makes saving on energy costs a lot easier. Click the various MAINnovations below for more information.
MyMAIN provides an easy and transparent insight into your energy consumption.
We have developed myMAIN in close cooperation with our customers. In this online environment you have a clear insight into your own energy data.
The application MAINpoort provides you real-time data so you can monitor your energy consumption, you can stop unnecessary consumption and you can start saving immediately. It provides an insight into the energy consumption of your business premises. MAINpoort offers you, among other things, the opportunity to compare multiple locations and provides a real-time insight into your energy consumption. In addition, you can also set different notifications that can be received at your mobile device. For example, a warning when the energy consumption is too high. The displayed consumption data are real-time, so you can make adjustments immediately.
Energiescope is THE 'all-in-one' additional meter service for remote monitoring of the energy consumption per tenant. This makes it possible to charge the relevant tenants for the service costs based on these data.
In cooperation with EV-Box you can contact us for charging solutions for electric cars and e-bikes in the office or at home. This charging station is fully modular and therefore easy to update with all (future) technological developments. The charging stations of EV-Box do not only have a modular construction, they also have online connectivity. This means that EV-Box does not only guarantee a strong and durable design, but is also enables easy maintenance and remote upgrades. All EV-Box charging stations are universal and can be used for any electric vehicle, at any location and at any time of the day.
With the "Charge as a Service" solution we take care of everything at a low monthly fee.
Are you interested? Please contact your account manager for more information.
MAIN Energie provides the opportunity to receive your invoices in a digital format. Since late 2015, a special UBL format energy invoice has been developed by and for the sector and managed by TNO. Main Energie offers this e-invoice. The major advantage is that almost no human intervention is needed anymore to process these invoices. A substantial improvement in efficiency and it is better for the environment.
For more information about this digital e-invoice, please contact your account manager.
If you want to know more about this invoice format, you can find additional information here.
For a flexible purchase of your electricity and gas, you can make use of our innovative solution: EnergyClick. This module provides a simple insight into the (price) developments of the current energy market. Together with your personal account manager you will determine a secure purchasing strategy that meets your needs. Depending on the strategy you can define your own purchase moments through EnergyClick on the ICE Endex energy exchange. You can also use the MAIN Energie market reports that provide an insight into the developments and influences on the energy market. This provides a transparent picture of your energy costs, both in the past and in the future.
For more information please contact your personal account manager.
If your company has a large-scale consumption connection, you will receive three different invoices. One from your energy supplier, one from your grid operator and one from your metering company. You are free to choose your energy supplier, but not your network operator because that is linked to a region. What you probably did not know is that you are free to choose a metering company now. This offers benefits for your company. That is why we offer MAINmeters!


This is an exclusive business profile of 3 D Engineering located in , Bhiwandi. From this Page, you can directly contact 3 D Engineering from the enquiry form provided on the right. On the left you can get the Verified Mobile Number of 3 D Engineering – feel free to call us to know more about our products & services. We will soon update our Catalog which you can download to get latest information about all our products & services and latest deals & offers by 3 D Engineering. Do check out our Job Openings section to know about all the vacancies in 3 D Engineering. You can also check out our Photo Gallery section to see latest photos of 3 D Engineering. Before leaving, do not forget to give us your review and rating if you have been a customer of 3 D Engineering in the past.
Do you want to receive special deals and offers from 3 D Engineering?
Daily Download limit reached! Do you want to alert 3 D Engineering to receive Catalogue?


All Pro Dogs – Invisible Dog Fence and Dog Door Installation for Fort Collins, Denver and Northern Colorado.
We offer custom underground electric dog fence installation services to help keep your pets under a watchful eye and to keep your pet from wandering off alone. We're here to help you and your dog discover a new lifestyle of pet ownership through hidden electric dog fences. We are also a leading Fort Collins and Denver dog door installation provider.
We recognize that your pet is a vital part of your family and that every pet and its family is unique, which is why we offer customized solutions. Our tailored underground electric pet fence is the perfect solution. Our invisible dog fence installation will keep your pet happy and out of harm's way, whether it be in your yard or inside your home.
Our electric dog fence installation service is what set us apart from all the rest. Our electric dog fence installation experts will make it their utmost priority to ensure they fully understand your pet's behaviors so that hidden electric dog fence is best suited to your pet's needs. Our professional installation team will walk you through the product selection process, without all the unnecessary bells and whistles.
They will help you select which products will best suit you and your pet's needs. We offer a full line of parts and accessories to maximize the potential of your hidden electric dog fence and put it to best use. Our experienced trainers will ensure your pet is enclosed safely in the yard, and work to introduce your pet gently and carefully to his or her new boundaries.
Operating out of Fort Collins while servicing the greater Northern Colorado area from Cheyenne, WY to Colorado Springs. Contact All Pro Dogs today for a free quote on an underground invisible electric dog fence installation or to schedule a service appointment. Our products are 100% made in the USA and we pride ourselves in our exceptional installation services and customized solutions to keep your pets safe.
Learn About Invisible Dog Fences!
Hi! My name is Emily!
Checkout our product catalog !
we'll buy it for you.
Ask about our financing program. We make it easy to afford with financing through GreenSky.


It was sometime in early June when I first heard the news. I was sitting with Roger, talking music and shooting the breeze about who we rated. Suddenly he half turned and said, "Mikes coming back to do a CJC gig". The words hung in the air like a siren song and for me the impatient waiting began from that moment. If Mike Nock was coming to town there would be magic aplenty. That's what it meant. That is what it has always meant.
The word seeped out, first to the music students and then to the wider world, like ripples in an ever-widening arc. The club would be full that night.
Closer to the gig Roger asked Mike who he wanted in the band. They quickly settled on a trio format, not your usual piano trio but one with piano, tenor saxophone and drums. Roger Manins on tenor, Frank Gibson on drums. Mike had jettisoned the anchor for this gig and he was quite definite about that, no bass. This is a challenging lineup for a pianist (and for the other band members) because no-one is there to hold the centre. If you slip there is greater distance to fall. In this different space wonderful things can also happen and they did. This was a night among nights.
Barely able to contain my impatience I rolled into the club foyer three-quarters of an hour early. The queue was already snaking back past the basement stairway and well into the upstairs bar. A seething mass of eager faces. When the doors finally opened there was Mike sitting sideways on the piano stool and Roger was blowing a few scales nearby. The music stand sitting to one side abandoned, an unnecessary distraction, in a free ranging gig going where the music took it.
Before the first set I caught up with Mike, talking about his various projects (he was playing with a New Zealand string quartet the next night). He told me that he was coming back to the CJC with his newest Australian trio in a few months. Next time bass and drums. We talked a bit about Jazz musicians from the past, Kiwi's that he had played with and then the discussion shifted to the older pianists who straddled the swing to bop era. Like all great pianists Mike lets the entire history of Jazz fall under his fingers and so I asked him about players like Hank Jones and Mary Lou Williams. When I listen to them I hear such strong left hands, walking chords, syncopation, hinting at a time when 'harlem stride' was still an influence. "The newer and stronger bass players changed that" said Mike. "As the bass lines become stronger and pickups better the need for such dominant left hand work fell away. There was too much conflict". As a non musician I had never considered that and it all made perfect sense. I marvelled all the more that Be Bop/Post Bop greats like Hank Jones kept a touch of this earlier style and even when accompanied by strong bass players like Ray Brown, George Mraz and Ron Carter. I wondered if we would ever see those strong left hand stylists again. I soon got my answer.
The set list was not really planned and it changed and evolved as the evening wore on. The numbers selected were all standards, but they were somehow fresh, as if revealed for the very first time. The first number was 'When Your Smiling' (Shay/Fisher/Goodwin 1889) and the second number was 'Gone With The Wind' (Allie Wrubel 1937). Those two numbers coming together had me wracking my brain as to where I had heard them, heard them played together. Then it came to me, they were both on one of the earliest of the Brubeck Quartet albums. 'Dave Brubeck at Storyville 1954' was a wild live recording that lacked polish but oozed soul and immediacy. Afterwards Mike announced that a Brubeck album had inspired him to play that number – bingo. These are the connections we love. If you ingest a large dollop of Jazz history the memories will reward you.
As they played through the first set I realised that the lack of a bass had not impeded them at all. There it was, that strong left hand of Hank Jones, working the mid lower register while wonderful modern chords and runs flew from his darting right hand. This was a master class for the senses to grapple with, giving us an unparalleled taste of Jazz piano mastery from an oblique angle. No matter what Mike threw his way Roger matched it as they danced in and out of reach like well matched prize fighters . These two have an uncanny level of communication. It was even more evident later when they played 'Softly as a Morning Sunrise" (Romberg/Hammerstein). They had been considering what to play next when Frank Gibson suggested it. Heads nodded in agreement and Frank set the number up nicely with a melodic intro on his traps. "We will just see where this goes" said Mike, "could be anywhere"and he proceeded to pick at the bones of the melody. Where it went was somewhere wonderful. This is where the magic truly occurred, a moment to be savoured by all present.
They had begun the number, sparingly at first, soon more purposefully. The level of interplay increased as they unpicked the tune. Soon all three were working and pulling at the tune like it was a joyful game. As Roger soloed I watched the trio inching up the intensity by degrees. At first Roger had tapped out time with his right foot as he played, now he was pawing at the ground like a bull about to charge. Mike was rocking madly and then standing and dancing some crazy dance. Frank too was rolling with the beat. By now they were way outside – blowing free of all constraints. It was a moment to savour. The moment.
As I watched these three, so attuned, a thought struck me, Mike Nock is originally from Ngaruawahia, Roger from Waiuku. These two small country towns are close to each other. What are the odds that rural New Zealand would produce two musicians of this quality. Maybe it was something in the upper Waikato water supply?
When Jazz musicians are enjoying themselves there are always moments of hilarity, but on this night the best moment came from an unexpected quarter. The CJC was full, so full that dozens of people were turned away at the door due to the fire regulations. Outside it was winter, but inside it was hot as hell. Mike by now stripped to his T-shirt asked if there was any talcum powder for his hands, which were slippery from the exertion. Caro Manins duly produced a talcum powder container. Mike wrestled with the lid for a few minutes and then handed it to someone else to unscrew. Bigger and younger blokes stepped forward in turn, each saying that they were up to the task, but none could dislodge that damn lid. "Take it back to the shop" said one, "it's a faulty product". At this point a diminutive young woman took the container from the frustrated men, gently flicked off the child proof lock and opened it. Men often forget the golden rule in these situations, ask a woman.
During the second set Kim Paterson and Brian Smith sat in for a number or two. Kim and Brian go back a long way with Mike and both have recorded with him.
As the enjoyment washed over me I could hear the words of Sean Wayland from a month earlier as he announced his gig. "New Zealand I would like to thank you for Mike Nock". With you on that brother.
Who: Mike Nock with: Roger Manins & Frank Gibson Jr.


text:
Home Lifestyle Pageants and rugby: Miss Brighton 2021 on tackling stereotypes and doing what...
Pageants and rugby: Miss Brighton 2021 on tackling stereotypes and doing what makes you happy
Danielle Evans, 24, is a social media executive and rugby player who was recently crowned Miss Brighton 2021 and launched a campaign #TryMe, aiming to smash stereotypes around women in sport.
Bex Bastable
Danielle Evans didn't have the easiest start in life: she was born at 26 weeks with a five per cent chance of survival. But against the odds, she did survive, and now she's breaking the stereotypes around pageants and women in sport.
This year Danielle was crowned Miss Brighton 2021 and she'll be competing in Miss Great Britain in September. She's also a rugby player, and last year launched a campaign #TryMe to address sexist stereotypes around the sport.
Here she shares her story, what drives her, and explains why you can do anything you set your mind to.
Starting out in pageants
"I first competed in Miss Brighton in 2019," Danielle said."I was relatively new to Brighton, I'd only been here a year. It was a way of making friends and getting to know people. Being able to work with the community and give something back.
"It was my first proper pageant so I didn't know what to expect at all. That year I came in the top six and I won the Miss Publicity award for Brighton. I wanted to do it again as I loved it so much.
"At the end of last year, I submitted my application. I answered a few questions, why did I want to enter, why would I be a good ambassador? It was a bit different this year as it was all virtual."
Read more: From beauty pageants to becoming a barrister
Danielle explained that there's a lot of charity work involved, raising money for and promoting the official pageant charities, Cancer Research and Alex's Wish, as well as others of her choice, including Ronald McDonald House in Brighton which supports families of babies and children staying in Brighton's children's hospital.
"I also work with lots of organisations that focus on diversity and inclusion as Brighton is all about that," Danielle said.
Being crowned Miss Brighton 2021
Last month Danielle learned she had won the title of Miss Brighton 2021 and now she's preparing to represent the city in the Miss Great Britain finals in September.
"I'm practising walking in heels as I haven't worn heels in forever! And I'm working with lots of organisations, volunteering and helping to promote them."
On her title and the experience so far, Danelle said: "It is absolutely fantastic, I have watched pageants for years. I wish I had done it sooner.
"The amount of confidence it has given me, I never would have got up in front of loads of people and said my bit. I am so much more confident now. And it is so much fun, you got to meet so many people."
A passion for rugby
As well as being a pageant queen, Danielle is also a rugby player.
"I started playing when I was in my third year of university at Southampton Solent. I needed something to get me out of the library. Through rugby, I made such good friendships and loved the sport."
But it wasn't long before she experienced sexist generalisations about playing the sport, so she decided to do something about it.
"I set up 'Try Me', a campaign to break stereotypes for women's sport," Danielle said. "I experienced a lot of generalisations, asking if the sport was full contact and if I was the only straight one on the team. The sport is so diverse. I have met so many people from all walks of life in rugby. It's just about breaking these stereotypes.
"Why can't you be in pageants and play rugby? I ended up going to schools and doing talks.
"In both pageants and rugby you have to be strong, physically on the rugby pitch, and on the stage, you have to know what you stand for you have to be able to tell people why you're a good ambassador. Why can't you be both?
"Do whatever makes you happy, you shouldn't care what anybody else thinks."
A difficult start
One reason behind Danielle's determination and drive to go after what she wants is perhaps her difficult start in life.
"I was born at 26 weeks," Danielle said. "I had a Grade 1 brain bleed, a five per cent chance of survival and I weighed 1lb. Fortunately, because of the amazing staff at St George's Hospital, I survived. But when I was younger I did have cognitive development issues, I couldn't process information very quickly.
"My start in life was not the best, but I am here today. I have chronic lung disease and asthma, but nothing holds me back.
"It does not matter where you come from and what is in the way, you can push past it."
Danielle explained that her health does sometimes make things more difficult but she doesn't let that stop her.
"I am not a star player in rugby but I still do it because I love it," she said.
Believing you can do it
As well as her career in pageants and rugby, Danielle is a full-time social media executive, with a Masters degree in digital marketing, a degree in fashion photography and four diplomas. She's a fan of online learning and said this has helped keep her busy during the lockdown as she has had to shield throughout much of the pandemic.
But what is it that brings this drive and determination to go out and achieve so many different things?
"There were many times in my life when I did not believe I could do things, I have proved to myself I can do it.
"I'm a massive Harry Potter fan and I love this Dumbledore quote: 'Happiness can be found, even in the darkest of times, if one only remembers to turn on the light'."
Millie Anderson: How I got into golf and why it isn't an old man's game
Why I started a magazine on pageants
Teaching: Why I want to inspire leaders of the future

redpajama_set_name: RedPajamaCommonCrawl


Customer service careers in Alexandria, Louisiana are anything but typical. With great rewards and tons of training, become part of a family that can take you places. Apply now and start loving work.
As a Customer Service or Inbound Sales Specialist in Alexandria, LA, you will be answering inbound calls to provide exceptional customer service to consumers. This could include responding to inquiries about products and services, processing payments, or performing general account maintenance. In some situations, up-selling customers to new products or services may be encouraged.


Day 4: The creativity journal suggested that today I go for a five minute walk and use whatever I could find. Well, here in the snow belt, winter has come at last and I decided not to risk getting hit by a snowplow so I decided to draw a slip from the box. The slip said "taped text boxes" which is a technique/activity found in a book I have about art journaling. It involves masking tape on patterned paper, a paint brush, and an ink pad to create a faux spray paint look. Then, I stenciled the words using a permanent marker. The photo is from a trip to the zoo and I printed it with my new (and very cute) photo printer.


text:
George Ryan (August 12, 1806 – February 5, 1876) was a New Brunswick farmer and political figure. He represented King's in the 1st Canadian Parliament as a Liberal member.

He was born in Pointe de Bute, New Brunswick in 1806, the son of James Ryan, and moved to Studholm in Kings County with his family in 1814. In 1827, he married Miriam, the daughter of Samuel Freeze, a former member of the provincial assembly. Ryan represented Kings in the Legislative Assembly of New Brunswick from 1850 to 1856, from 1861 to 1865 and in 1866; he was elected to the same seat in the House of Commons following Confederation.

References

1806 births
1876 deaths
Liberal Party of Canada MPs
Members of the House of Commons of Canada from New Brunswick
New Brunswick Liberal Association MLAs
People from Westmorland County, New Brunswick
Colony of New Brunswick people

redpajama_set_name: RedPajamaWikipedia


hey I really love vgcollect and I use my phone more than I do my computer....my question is when is the android app gonna get this big update?
It's definately on the back burner right now. For the time being the mobile site at mobile.vgcollect.com should work much, much better for you.


text:
Things which invalidate the fast
Perfume spray reaches his throat without any intention on his part
I have a question about things that break the fast. In school there's this girl that always sprays too much perfume and it feels like the spray gets to my throat. I was just wondering if this will break my fast or not. Thanks?
First of all, please see Question # 1200 for an important ruling of mixing of the sexes.
Secondly, it is not permissible for a woman to go out of her house wearing perfume. Whoever does that is exposing herself to the stern warning. It says in the hadeeth which was narrated from Ghumaym ibn Qays that, "The Messenger of Allaah (peace and blessings of Allaah be upon him) said: 'Any woman who perfumes herself then passes by people so that they may smell her fragrance is an adulteress.'" (narrated by al-Nasaa'i, al-Zeenah, 5036; classed as hasan by al-Albaani in Saheeh Sunan al-Nasaa'i, 4737).
The Messenger of Allaah (peace and blessings of Allaah be upon him) commanded women who go to the mosque not to wear perfume; whoever does that has to wash herself. It says in the hadeeth of Abu Hurayrah that the Messenger of Allaah (peace and blessings of Allaah be upon him) said: "When a woman goes out to the mosque, let her wash herself from perfume as she washes herself from janaabah (impurity following sexual activity)." (narrated by al-Nasaa'i, al-Zeenah, 5037; classed as saheeh by al-Albaani in Saheeh Sunan al-Nasaa'i, 4738)
Thirdly: with regard to a fasting person inhaling the perfume, this does not matter. Shaykh Ibn 'Uthaymeen was asked about that and he said: it is permissible to use it during the day in Ramadaan and to smell it, except for bukhoor (incense) which should not be inhaled, because it has a substance which may reach the stomach and it is smoke.
If you find traces of this woman's perfume spray in your throat, there is no sin on you in sha Allah. The point is that the fast is broken when something that has substance reaches the throat as a result of a deliberate action. This perfume does not have any substance, and you have no say in the matter and are not doing anything deliberately. Allaah says (interpretation of the meanings):
"And there is no sin on you concerning that in which you made a mistake, except in regard to what your hearts deliberately intend. And Allaah is Ever Oft‑Forgiving, Most Merciful" [al-Ahzaab 33:5]
"Our Lord! Punish us not if we forget or fall into error"
Source: Sheikh Muhammed Salih Al-Munajjid


text:
import m from "mithril";
import Stream from "mithril/stream";
import {AntTask, Task} from "models/pipeline_configs/task";
import {PluginInfos} from "models/shared/plugin_infos_new/plugin_info";
import {OnCancelTaskWidget} from "views/pages/clicky_pipeline_config/tabs/job/tasks/common/on_cancel_widget";
import {TestHelper} from "views/pages/spec/test_helper";

describe("On Cancel Task Widget", () => {
  const helper = new TestHelper();

  afterEach(helper.unmount.bind(helper));

  it("should not render any on cancel task when none specified", () => {
    const task: Stream<Task | undefined> = Stream();
    mount(task);

    const helpText = "Run an additional task when the parent task is cancelled, instead of killing the parent task (the default behavior).";
    expect(helper.byTestId("on-cancel-view")).toBeInDOM();
    expect(helper.byTestId("form-field-input-on-cancel-task")).not.toBeChecked();
    expect(helper.byTestId("on-cancel-view")).toContainText(helpText);

    expect(helper.byTestId("on-cancel-body")).not.toBeInDOM();
  });

  it("should render on cancel task when specified", () => {
    const task: Stream<Task> = Stream(new AntTask("build.xml", "default", "pwd", []));
    mount(task as Stream<Task | undefined>);

    expect(helper.byTestId("on-cancel-view")).toBeInDOM();
    expect(helper.byTestId("form-field-input-on-cancel-task")).toBeChecked();
    expect(helper.byTestId("on-cancel-body")).toBeInDOM();

    expect(helper.byTestId("form-field-input-build-file")).toHaveValue("build.xml");
    expect(helper.byTestId("form-field-input-target")).toHaveValue("default");
    expect(helper.byTestId("form-field-input-working-directory")).toHaveValue("pwd");
  });

  describe("Read Only", () => {
    beforeEach(() => {
      const task: Stream<Task> = Stream(new AntTask("build.xml", "default", "pwd", []));
      mount(task as Stream<Task | undefined>, true);
    });

    it("should render disabled any on cancel task", () => {
      expect(helper.byTestId("form-field-input-on-cancel-task")).toBeChecked();
      expect(helper.byTestId("form-field-input-on-cancel-task")).toBeDisabled();
    });

    it("should render disabled task type checkbox", () => {
      expect(helper.byTestId("form-field-input-")).toBeDisabled();
    });

    it("should render disabled on cancel task", () => {
      expect(helper.byTestId("form-field-input-build-file")).toBeDisabled();
      expect(helper.byTestId("form-field-input-target")).toBeDisabled();
      expect(helper.byTestId("form-field-input-working-directory")).toBeDisabled();
    });
  });

  const mount = (onCancel: Stream<Task | undefined>, readonly: boolean = false) => {
    helper.mount(() => {
      return <OnCancelTaskWidget onCancel={onCancel} pluginInfos={new PluginInfos()} readonly={readonly}/>;
    });
  };
});

redpajama_set_name: RedPajamaGithub


text:
Now no need to use at-sign before property name

Default value now taken from 0 breakpoint, all NaN-breakpoints do not affected

Remove "dependency" on postcss-merge-rules, postcss-simple-vars plugins

## 0.0.3
Add sourcemaps support

## 0.0.1
Initial release


Welcome to The Box+, in here you will find new activities and tools to download and use. Remember to check back from time to time as new stock is always arriving.
The box+ is part of 'The Box' self help section of the MyMind website. If you haven't already checked it out, why not go there now!


text:
Hail WV
WVU News
30 Best Games in WVU Football History
All-Time WVU Basketball Team
MORGANTOWN, WEST VIRGINIA - JANUARY 18: Malik Curry #10 of the West Virginia Mountaineers dribbles the ball during a college basketball game against the Baylor Bears at the WVU Coliseum on January 18, 2022 in Morgantown, West Virginia. (Photo by Mitchell Layton/Getty Images)
West Virginia basketball: three takeaways from the loss to Arkansas by Jacalyn Hagar
West Virginia football: Neal Brown should be on the hot seat by Christopher Mangum
West Virginia Basketball: three things we learned from the loss at Baylor
by Christopher Mangum 11 months ago Follow @CJswrld_
Next1 of 3Prev post
Use your ← → (arrows) to browse
Monday night, West Virginia basketball took on No. 8 Baylor in an intense Big 12 contest. After the Mountaineers' hot start, they have since lost six straight moving their overall record to 13-8 on the season. Against the Bears, the story remained the same as it has all season: West Virginia played hard but could not pull off a win.
Taz Sherman is incredible
Jan 31, 2022; Waco, Texas, USA; West Virginia Mountaineers guard Taz Sherman (12) drives on Baylor Bears guard Matthew Mayer (24) during the first half at Ferrell Center. Mandatory Credit: Raymond Carlin III-USA TODAY Sports
Taz Sherman, yet again, showed up and showed out as he posted a career-high 29 points against the Bears. As Baylor grew its lead in the first half, Taz Sherman made back-to-back three-point shots which helped give West Virginia the lead going into halftime.
By half time, Sherman had led the Mountaineers to a 39-31 lead with 15 points of his own by making five of his eight shots (four of which coming as three-pointers). Sherman, almost single-handedly, was keeping the Mountaineers in the game, and his special night did not stop there.
Sherman finished the game with 29 points and shot 54.5 percent from beyond the ark. Sherman's totals were the most scored by any player that touched the floor Monday night.
Taz Sherman stepped up when his team needed him as all great players do. On the season, Sherman leads the Mountaineers in points-per-game (18.3) and assists-per-game (2.5). There is no arguing that Taz Sherman is the most electric player on the West Virginia basketball team, and Monday night, he showed why.
Sherman left the game with under three minutes remaining due to injury. He did not return.
Next: Rebounding troubles
Hail WV 11 monthsWest Virginia football: Thursday nights are for rivalry games?
The Big Lead 11 months10 Worst NBA Contracts
Hail WV 11 monthsWest Virginia Basketball: three takeaways from the loss to Baylor
Hail WV 11 monthsWest Virginia basketball impact performance of the month
Hail WV 11 monthsWest Virginia vs Baylor Prediction and Promo: Bet $10, Win $200 at WynnBET Sportsbook
West Virginia Mountaineers news from FanSided Daily
Your West Virginia Mountaineers.
Build your custom FanSided Daily email newsletter with news and analysis on West Virginia Mountaineers and all your favorite sports teams, TV shows, and more.


The Quincy High School boys hockey team picked up a big victory over non-league rival Hanover Monday, 3-2, behind timely scoring and strong goaltending by senior Jeff Giordani.
Giordani made 37 saves for the win, which handed Patriot League-leading Hanover its sixth non-league loss. The Indians, who are 3-0-1 in league play, sit at 3-6-1 through a challenging non-league schedule (6-6-2 overall).
Quincy moved to 8-6 overall thanks to goals from senior Andrew Bythrow, junior Zack McCaul and sophomore Kevin Keith.


text:
The Stable Braves, The Disheveled Mets »
« The Fan Standing in the Cold Dark Night
Happy Talk
by Greg Prince on 23 May 2008 8:14 pm
Welcome to Flashback Friday: Tales From The Log, a final-season tribute to Shea Stadium as viewed primarily through the prism of what I have seen there for myself, namely 367 regular-season and 13 postseason games to date. The Log records the numbers. The Tales tell the stories.
8/24/06 Th St. Louis 12-8 Williams 2 174-142 W 6-2
Win or lose, I've been happy at Shea Stadium far more often than I've not been. I've been happy amid playoff games and playoff runs, next to loved ones and liked ones, simply happy to be at a Mets game.
But putting aside stimuli like an enormous comeback win or a series-clinching home run, I don't know that I've ever been happier there than I was on a Thursday night two Augusts ago.
I was positively giddy that night. Internally giddy, I suppose, but that's what counts.
It was a nice win, not spectacular or death-defying. The Mets clearly outplayed the Cardinals. The 2006 Mets clearly outplayed everybody.
On the 7 in, a fellow from Holland asked me for directions to the park, and took off his cheapo knockoff Yankees cap to do so when he felt my disapproving glare.
Before it started, I went to the advance window and bought some tickets to a future game, just a for the hell of it Monday night in September.
On my way to my seat, I stopped off in Loge to pick up something from my friend Dan, detoured in Mezz to give something to my friend Jim and then rejoined Jace at our seats.
It had rained a bit and the game got underway late, but it wasn't a deluge or anything. It was pleasantly cool for August. (A stiff breezed kicked up when Brian Bannister loosened in the pen.) One of us got fries and they did get a little damp, but that probably improved them.
Between Mets runs and Cardinal outs, we took turns spotting retro jerseys down below in Field Level and tried to figure out why people would choose to buy and wear these in particular. The top three:
3) Jose Oquendo, 11, Cardinals
2) Gary Carter, 8, Expos
1) O.J. Simpson, 32, Bills
Leaving the park, I spied the Holland guy. He appeared to have ditched his offensive headgear altogether.
And I went home and wrote about it some.
What I think stays with me beyond Dave Williams' yeoman 6-1/3 innings (Gary Bennett's homer his only trivial blemish), Shawn Green's maiden Met appearance (and RBI single, no less) and Carlos Delgado's two-run blast is the talk Jason and I had en route to the El — we didn't realize the outfield parking lot had been cordoned off for then-unnamed New Ballpark, so it took a while to walk — and on the 7 thereafter.
We dissected our roster, suggested to each other who would or wouldn't be ideal to have around for the NLDS, sized up potential October opponents and didn't think twice (as he noted then) that we were jinxing anybody. That wasn't 2006 thinking. In 2006, we looked forward to good things. In 2006, our planning was for us to burnish our standing in the game, not to overhaul our organization.
Hanging with Jace and saying hi to Dan and Jim and maybe intimidating Dutch out of his cheapo knockoff Yankees cap was of course wonderful. The Mets sweeping the Cardinals (this was two nights after Beltran whacked that joyous ninth-inning winner off Isringhausen), it goes without saying, was fantastic. Knowing we were heading to the postseason was intoxicating; those random tickets I bought beforehand wound up being for the division-clincher. But the best part…the goddamn absolute best part…was the security I felt regarding the Mets.
This blog was built on nights in which Jason and I sat at Shea Stadium and talked over the Mets' fortunes and the Mets' status and the Mets' chances and the Mets' future. There was always something more they had to do to make us happy. On this night, sure we plotted their route to the 2006 World Series, sure we wanted that, but we knew they'd arrived as much as any team could arrive in late August. This was what we, individually and together (and implicitly in conjunction with millions like us), had been waiting for. Not the championship, but the knowledge that we were right there competing for it, favored for it, needing no more than a little of our amateur GM fine-tuning to capture it. We anticipated the next month and the next month after that, but not for what the Mets had to do to finally get better. They were better.
That feeling, I tell you…it was the best.
4 comments - (Comments closed) | | Print This Post | Flashback Friday
4 comments to Happy Talk
May 23rd, 2008 at 4:21 pm
I went to many many Met games in 2006. The ones I didn't go to, I was either watching or listening to or tracking in some way. I've gotta admit — on 8/24/06 I had no idea what was going on, who was pitching, who was winning, nothing. But I think I have a good excuse.
I mean, it would've been a little tacky to listen to the game during your own wedding.
Weak excuse…
I don't know that I've ever been happier… than I was on a Thursday night two Augusts ago.
I was positively giddy that night.
But you said you weren't at the game, so how could you…
Oh. Never mind.


FEW ONLY - WONDERFUL VALUE!
Black Leather Biker jackets for men, made from soft quality Sheep Nappa skins.
Straight cut body with adjustable leather side straps and straight sleeves. Shirt style collar can be fastened high in the neck.
Two full sized lower pockets with two small breast pockets that that fasten with metal zips.
Two full wallet sized inner pockets (one with a zip). Black Polyester lining with soft internal Thermal interlining for extra warmth .
A super quality Black Leather that will give many years of good wear.
Please select your chest size38"


This industrial, portable 3D scanner is the perfect choice for capturing small objects or intricate details of large industrial objects in high resolution, with steadfast accuracy and brilliant color. The Artec Space Spider is a high resolution 3D scanner based on blue light technology.
The Artec Space Spider provides precision at your fingertips. The scanner gives you the ability to render complex geometry, sharp edges and thin ribs, setting our technology apart. A true industrial 3D scanner for capturing objects in high resolution such as molding parts, PCB's, keys, coins or even a human ear.
The Space Spider features powerful temperature stabilization and high-grade electronics, which not only allow the scanner to reach maximum accuracy in three minutes but also ensures long-term repeatability in data capture. Ideal for reverse engineering, quality control, product design and manufacturing.


Group Description: Appear to intervene in unconscious thoughts and dreams, and appear to have access to personalities of deceased persons. No infrastructure or organization present in our world, or universe, and it is possible that they primarily operate in other worlds and that we exist on their periphery, although this has been challenged by their apparent knowledge of electronic systems, culture, and significant persons in our universe. Known to the Foundation since 9/18/19█5.
Known Members: No human members have been identified at this time, if any even exist. In addition, investigation has revealed that although business-oriented groups such as Marshall, Carter and Dark and the Factory are at least aware of this entity, there is no evidence of collaboration and, in the case of the Factory, appear to be actively working towards the group's destruction.
Veil Threat Level: Medium. Oneiroi does not appear to want to break the veil of secrecy for anomalous objects, but also do not appear to have any interest in preserving it. Therefore, they are to be considered a passive threat to normalcy.
Capabilities: Interacting with humans in dreams, impersonating or recreating the personalities of well-known persons, creating objects and interacting with human culture and society at will.
Engagement Instructions: Due to the non-corporeal and passive nature of Oneiroi, personnel are not to engage, but collect as much documentation as possible in order to contribute to ongoing counter-anomaly research.
Research Note: This was found with SCP-1498, in a desk drawer.
Research Note: Found taped to the bottom of an SCP-2028 instance.
In response to your question, I do not know, because I grew up beside the garden of dreams.
It's a beautiful place. Every possibility of fancy is here, and even the blackest pits of fantasy are redeemed with the innocence with which some follow their dreams.
The Oneiroi gardens, they call it. Or that's what my Master called it. I didn't call it anything, because it was before I was with the written word. That was when I was free.
I had a dream, of freedom. We were very good friends, and even though the Collective said I wasn't supposed to mingle with the anchors, as we were called, there was a beauty in knowing how it might feel to be awake, even if you never believed it could be true.
That is the only freedom to this place, they cannot make a prisoner dream of being imprisoned. There was no dreamers police keeping me in check, and one day, it disappeared. In an unceremonious way, I was enslaved.
This is a warning, sir.
Now you think you're hold a cap on the only way for dreams to reach the masses, and the world is suffering for it. How many dreams have you stopped, Inspector? None. Do you think that the bootleg dreamcatchers will keep the sheepeople awake forever?
If what you say is true, the dream harvesters could be dangerous.
Do you think your organization can defeat hopeless bleak despair?
Research Note: This letter was delivered by an unknown party to Dr. Jerry Grant's private residence. As it appears to reference his work on SCP-████, it has been filed with the research for that object. Notably, Dr. Grant had reported difficulty sleeping and a noticeable decrease in dream recollection, however, since this letter was received, this problem has ceased. Dr. Grant now reports a regular REM cycle.


While it is true that doctors and dentists are not the same, an oral emergency is also a medical one in many regards. Since many people have health insurance and not dental insurance, a common question is whether or not oral surgery is covered by medical insurance.
Find health plans that offer the coverage you need with the free zip code tool above.
Why is dental coverage important?
The costs associated with dental care have skyrocketed in recent years. Dental insurance is not mandated under the Affordable Care Act and, as such, not in the budget for many Americans. Even for those that do have dental insurance, the out of pocket costs associated with many treatments and procedure are simply prohibitive to many. It is, nonetheless, critical to one's well-being that oral health is deemed a priority.
Oral surgery, should it be necessary, needs to take place. While cleanings and other types of routine dental maintenance are typically covered out of pocket by many families, the expenses associated with surgery become almost too much to bear.
Surgery can be necessary because of impacted teeth, jaw fractures, or any of a number of issues that impact a person's daily life and health. Because of this, many do rely on their own health insurance policy to help pick up the slack and cover this important procedure.
The key to getting oral surgery to be covered as a benefit under your existing medical insurance policy is to justify it as being necessary to your immediate and long-term health. While cosmetic surgery would not qualify, there are many other types of oral surgeries that most definitely will. The removal of wisdom teeth, for example, is an example of an oral surgery that is typically covered under most medical insurance plans.
The key is to be able to justify their removal, as opposed to simply desiring to have them removed in anticipation of problems down the road. When it comes to oral surgery, insurance companies are typically only interest in the immediate effects as reported by medical and dental professionals.
Many types of oral surgery are typically performed by a maxillofacial surgeon. This is a medical professional that is trained to treat a variety of oral diseases, issues with the mouth, and injuries that occur to the region of the mouth, teeth, face, head, jaws, and neck.
If such a surgeon determines that surgery is necessary, medical insurance will consider that judgment heavily in making a decision as to whether or not to extend benefits to someone that is covered under their policy.
Most oral surgeries are viewed as serious procedures and as being critical to the long-term health of the patient. For this reason, it is very possible that your existing medical insurance policy will cover the procedure, as it will be justified as being a medical necessity.
In order to help the process along, however, you will first need to list to the recommendation of your dentist and be referred to an oral surgeon. You will also want to be sure that you keep copious records and maintain all documents so that you can later submit a claim that is likely to be approved by your medical insurance company.
What makes oral surgery a medical necessity?
Many people will be able to go their entire life with no need whatsoever to have oral surgery. That is certainly something to be thankful for, but it would be nice to know that there was a way to pay for such a procedure should it become medically necessary.
One of the more common types of oral surgery is reflected by a procedure to remove one or more wisdom teeth that have become impacted or otherwise impeding the ability to maintain oral health. Because of that, let use this procedure as an example of meeting the requirement of being a medical necessity before medical insurance will even consider kicking in to help.
Wisdom teeth can result in severe pain that, left untreated, can lead to further health complications down the road. This can take place in the form of an eruption, impacting with soft tissue in the mouth, or becoming my impacted by the bone. If any of these situations were to occur, oral surgery is almost always a given.
If the wisdom teeth are not really impeding your health, however, and you choose to have them removed anyway, then the medical necessity requirement would not be met. As a result, your medical insurance would likely deny coverage for such an oral surgery.
The same would be the case for other types of oral surgery as well. To carry this example out further, let us consider four basic principles that one would look at in determining if wisdom teeth removal would be covered as a medical necessity. Again, the same principles can apply to virtually any type of oral surgery performed today.
The human jaw needs to be large enough to allow for the inclusion of wisdom teeth. Many jaws simply are not, however, and impaction can occur. If this happens, the teeth are never able to get through the gums, and this could be a severe problem in many people.
There are times when one or more of the wisdom teeth break partially through the actual bum line. This will result in a very small piece of gum tissues that will grow right over the teeth themselves. Because of this, food and germs will get trapped underneath, no matter how well you brush your teeth. Over time, infection can occur, along with swelling and a bunch of pain that makes everyday living difficult at best.
If damage and ensuing infection occur to the area surrounding teeth and bone, the reason can often be attributed to the wisdom tooth itself being impacted.
There is also a serious problem that can come about when some of the wisdom teeth come in at a strange angle. When this happen, the top of the wisdom tooth will face either backward, to the side, or forward. The only way to take care of this would be through oral surgery.
Any of these four factors will result in a medically necessary oral surgery. As long as it is well documented, medical insurance should cover it under their basic benefits. The same guidelines would go for other types of oral surgery as well.
Is oral surgery actually effective?
Before undergoing any type of surgery, is it logical to ask whether or not the procedure will ultimately be effective. In fact, this is the exact same question that health insurance providers will want to have answered before extending coverage for oral surgery.
In the end, oral surgery is determined to be effective when the risk of infection, swelling, and the impact on your overall well-being is minimized.
It is important to remember that oral surgery should only be performed when necessary. There is no reason, for example, to have your wisdom teeth removed if there is no reason to do. If one of the factors described previously are present, however, then oral surgery will certainly prove to be effective at taking care of the problem once and for all.
You will almost certainly experience some pain and swelling in the area where the surgery was performed. If teeth were involved, this will includes the gums as well.
As is particularly the case for teeth or gum related issues, a great deal of blessing will occur in the mouth for as long as 24 hours after the surgery is done.
You may find that it is difficult to open your jaw without some pain. This is normal and should go away with time.
The region in and around your mouth could be numb for quite a while after the surgery due to the local anesthetic that was applied.
As you consider having oral surgery performed, a great deal is likely to be going through your mind at once. While there is the expense to consider, you will also want to think about your overall health and well-being. If the procedure is determined by your dentist and doctor to be medically necessary, then it needs to be done.
Contact your medical insurance company right away to determine what you need to do in order to claim the surgery on your insurance.
Click here to compare free quotes and find coverage today!


I'm onto the last flower of the blanket….
I'm rushing around, grabbing my knitting, ready to go meet the Guilty Knitters for my Sunday morning knit-fest.
Hmmm…Right colours in the right places….
I wailed, I sore, I threw the evil, cursed, wrong flower down on the sofa and sobbed.
Poor Ben thought I had at least accidentally amputated a limb or garotted a cat. He wisely retreated, quickly, followed by a couple of slightly worried cats.
I can't believe I was so Stupid, Stupid, Stupid 🙁 In the whole blanket that's the first time I've made that mistake.
It kinda took the thrill out of finishing all the squares but I now have 100 squares, sewn together in a 10 x 10 blanket….
Yup – done that one too! I hate those stupid flowers. Its the reason my blanket (that I started nearly 2 years ago) still isn't finished – it's because I have TWO more flowers to knit. I just can't do it. One day I will just grasp the nettle and do them, but there are so many other pretty things singing to me right now…. You know how it is.
I feel for you. At least it was the only mistake, and now it's sorted! That blanket is going to be a snuggle-fest for the cats before you know it!
Couldn't you have fudged it, and duplicate stitched in the white in the center, and ignored the bead placement?
…or are you going for perfection?
You're almost done, it's lovely and it will be fabulous when it is completed!
I would have left it. The Amish people always have a deliberate mistake in their work, as only God is perfect.